NEW YORK (GenomeWeb News) – German regulators have cleared Hologic's $3.7 billion purchase of Gen-Probe, the two companies said today.

The deal, under which Hologic will pay $82.75 for each share of Gen-Probe stock, cleared US antitrust review last month and with clearance from Germany's Federal Cartel Office, required antitrust clearances have been received, the companies said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genomic study of group B Streptococcus evolution, selection on the X chromosome in great apes, and more.

Changing the fat and fiber content of people's diets affects their gut microbiome, metabolome, and colon cancer risk, researchers say.

Broken links are found throughout academic publications, and some services are trying to combat such link decay.

Nick Stockton at Wired says that a pause in studying genome-editing tools should be used to find a path forward.